{'fraction_non_alphanumeric': 0.011235955056179775, 'fraction_numerical': 0.0028089887640449437, 'mean_word_length': 4.95, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Commentary: Iloprost for cholesterol emboli syndrome

The following letter was commissioned by the BMJ as a commentary to accompany the research pointer published on 2 February. Owing to a failure of our processes we did not publish the commentary alongside the article. We are therefore publishing it now with apologies to Professor Pusey and our readers.